Although BRD9 inhibition suggested tumor progression through regulating PDAC cell growth in our cell-line xenografts, the cell-line xenografts do not accurately recapitulate the histopathological and molecular characteristics of the human parental tumor. Here, BRD9 is linked to neoplasm.